למיזיל טבליות 250 מ"ג

Country: Iżrael

Lingwa: Ebrajk

Sors: Ministry of Health

Ingredjent attiv:

TERBINAFINE HYDROCHLORIDE 281.25 MG

Disponibbli minn:

NOVARTIS PHARMA SERVICES AG

Kodiċi ATC:

D01BA02

Għamla farmaċewtika:

TABLETS

Rotta amministrattiva:

PER OS

Manifatturat minn:

NOVARTIS PHARMACEUTICALS LTD, UK

Grupp terapewtiku:

TERBINAFINE

Indikazzjonijiet terapewtiċi:

Fungal infections of the skin caused by dermatophytes such as trichophyton (e.g. rubrum, t. mentagrophytes, t. verrucosum, t. violaceum), microsporum canis and epidermophyton floccosum. Oral Lamisil should only be used to treat extensive, severe ringworm infections ( tinea corporis, tinea cruris and tinea pedis). Oral Lamisil is not effective against vaginal candidiasis or pityriasis (tinea) versicolor. Onychomycoses ( tinea unguium, ringworm of the nails) due to infecton with dermatophyte organisms ( hyphomycetes).

Data ta 'l-awtorizzazzjoni:

2009-09-01